Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Future Medicinal Chemistry|March 24, 2011
Novel heterodimer antibiotics: a review of recent patent literatureDaniel D Long, Daniel G MarquessNaunyn-Schmiedeberg'S Archives of Pharmacology|April 4, 2013
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonistPamela R Tsuruda, Ross G Vickery, Daniel D Long, et al.Bioorganic & Medicinal Chemistry Letters|May 14, 2017
Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonistsLan Jiang, David T Beattie, John R Jacobsen, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2013
Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic propertiesR Murray McKinnell, Scott R Armstrong, David T Beattie, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|March 21, 2013
The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activityScott R Armstrong, Christina B Campbell, Carrie L Richardson, et al.The Journal of Organic Chemistry|March 12, 2005
Helix-forming carbohydrate amino acidsTimothy D W Claridge, Daniel D Long, Christopher M Baker, et al.The Journal of Antibiotics|January 27, 2009
A multivalent approach to drug discovery for novel antibioticsDaniel D Long, James B Aggen, Burton G Christensen, et al.Bioorganic & Medicinal Chemistry Letters|January 16, 2013
A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucomaDaniel D Long, Bryan Frieman, Sharath S Hegde, et al.Bioorganic & Medicinal Chemistry Letters|June 12, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749Daniel D Long, Scott R Armstrong, David T Beattie, et al.Journal of Medicinal Chemistry|August 12, 2009
A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonistsR Murray McKinnell, Scott R Armstrong, David T Beattie, et al.Pageof 2